Treatment with RG7388 induces functional activation of the p53 pathway and apoptosis of neuroblastoma cell lines in vitro (164), and combination therapy with RG7388 treatment and chemotherapeutics demonstrated increased apoptosis in p53 wild-type neuroblastoma cells (165). Here, TP53 is linked to neuroblastoma.